Systolic blood pressure was higher in patients using TNF inhibition (RA, DMARD: 131 ± 22; RA, TNF inhibition; 151 ± 20, p <0.05 versus all other groups) (Table 1). The gene discussed is TNF; the disease is rheumatoid arthritis.